Michael Decker, Yu-Gui Si, Brian I Knapp, Jean M Bidlack, John L Neumeyer
Index: J. Med. Chem. 53(1) , 402-18, (2010)
Full Text: HTML
The phenolic group of the potent mu and kappa opioid morphinan agonist/antagonists cyclorphan and butorphan was replaced by phenylamino and benzylamino groups including compounds with para-substituents in the benzene ring. These compounds are highly potent mu and kappa ligands, e.g., p-methoxyphenylaminocyclorphan showing a K(i) of 0.026 nM at the mu receptor and a K(i) of 0.03 nM at the kappa receptor. Phenyl carbamates and phenylureas were synthesized and investigated. Selective o-formylation of butorphan and levorphanol was achieved. This reaction opened the way to a large set of 2-substituted 3-hydroxymorphinans, including 2-hydroxymethyl-, 2-aminomethyl-, and N-substituted 2-aminomethyl-3-hydroxymorphinans. Bivalent ligands bridged in the 2-position were also synthesized and connected with secondary and tertiary aminomethyl groups, amide bonds, and hydroxymethylene groups, respectively. Although most of the 2-substituted morphinans showed considerably lower affinities compared to their parent compounds, the bivalent ligand approach led to significantly higher affinities compared to the univalent 2-substituted morphinans.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Cyclobutylmethyl bromide
CAS:17247-58-4 |
C5H9Br |
Function-oriented biosynthesis of beta-lactone proteasome in...
2009-10-08 [J. Med. Chem. 52(19) , 6163-7, (2009)] |
Replacement surgery with unnatural amino acids in the lock-a...
2006-09-01 [Chem. Biol. 13(9) , 929-36, (2006)] |
10-Ketomorphinan and 3-substituted-3-desoxymorphinan analogu...
2004-01-01 [J. Med. Chem. 47 , 165, (2004)] |
Photochemical synthesis and antimicrobial studies of new chr...
[Arabian Journal of Chemistry , (2013)] |
Cyclopropylmethyl-and cyclobutylmethyllithium by an arene-ca...
[Tetrahedron 66(16) , 2928-35, (2010)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved